Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of TG Therapeutics Inc (NASDAQ: TGTX) closed at $45.51 in the last session, up 3.76% from day before closing price of $43.86. In other words, the price has increased by $3.76 from its previous closing price. On the day, 3.27 million shares were traded. TGTX stock price reached its highest trading level at $45.83 during the session, while it also had its lowest trading level at $42.76.
Ratios:
We take a closer look at TGTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.03 and its Current Ratio is at 6.25. In the meantime, Its Debt-to-Equity ratio is 1.14 whereas as Long-Term Debt/Eq ratio is at 1.14.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on October 29, 2024, initiated with a Buy rating and assigned the stock a target price of $50.
On August 02, 2023, Goldman Upgraded its rating to Neutral which previously was Sell and also lowered its target price recommendation from $16 to $12.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 03 ’25 when Power Sean A sold 11,337 shares for $30.29 per share. The transaction valued at 343,443 led to the insider holds 670,632 shares of the business.
Power Sean A sold 10,021 shares of TGTX for $285,939 on Jan 06 ’25. The CFO now owns 660,611 shares after completing the transaction at $28.53 per share. On Jan 06 ’25, another insider, Power Sean A, who serves as the Officer of the company, bought 10,021 shares for $28.53 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGTX now has a Market Capitalization of 7148301312 and an Enterprise Value of 6552660480. As of this moment, TG’s Price-to-Earnings (P/E) ratio for their current fiscal year is 326.00, and their Forward P/E ratio for the next fiscal year is 23.74. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.09. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.96 while its Price-to-Book (P/B) ratio in mrq is 31.89. Its current Enterprise Value per Revenue stands at 19.917 whereas that against EBITDA is 156.027.
Stock Price History:
The Beta on a monthly basis for TGTX is 2.21, which has changed by 1.77162 over the last 52 weeks, in comparison to a change of 0.09969199 over the same period for the S&P500. Over the past 52 weeks, TGTX has reached a high of $43.98, while it has fallen to a 52-week low of $12.93. The 50-Day Moving Average of the stock is 20.99%, while the 200-Day Moving Average is calculated to be 54.44%.
Shares Statistics:
According to the various share statistics, TGTX traded on average about 2.68M shares per day over the past 3-months and 2217250 shares per day over the past 10 days. A total of 155.84M shares are outstanding, with a floating share count of 142.96M. Insiders hold about 9.96% of the company’s shares, while institutions hold 61.63% stake in the company. Shares short for TGTX as of 1744675200 were 23543502 with a Short Ratio of 8.78, compared to 1741910400 on 26233481. Therefore, it implies a Short% of Shares Outstanding of 23543502 and a Short% of Float of 16.540001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
